Update of the 2009 started Periodic Assessment of molecular diagnostics from the end user perspective. Hospital and private laboratories have systematically been surveyed to collect information on number of labs testing, NA tests, test volumes, used platforms (separated for amplification, hybridization, detection) and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied: Step 1: Identification of the total number of labs Step 2: Identification of the total number of laboratories using NA technologies (in several lab units per hospital) Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 38 NA tests has been provided to the labs for structured data entry. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), Traditional and Next Generation Sequencing, TMA, LCR, NASBA, SDA, HCA, bDNA.
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Apr 2021
Global In Situ Hybridization (ISH) Market 2021-2025 The analyst has been monitoring the in situ hybridization (ISH) market and it is poised to grow by $ 475.05 mn during 2021-2025, progressing at a CAGR of about 7% during the forecast period. Our report on in situ hybridization (ISH) market provides a holistic analysis,...
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains...
Report Scope: The scope of this report is broad and covers the components available in the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics market and potential end-users. Revenue forecasts from 2020 to 2025 are given for types of kits and equipment, with estimated value derived from the revenues of manufacturers. The...
KEY FINDINGS The North America precision medicine market is projected to evolve with a CAGR of 9.67%, over the forecast years of 2021 to 2028. The region’s key market growth drivers include the rising focus of well-established diagnostics manufacturers to expand their portfolio in NGS-based molecular diagnostics, as well...
The global veterinary diagnostics market grew at a CAGR of around 7% during 2014-2019. Veterinary diagnostics refer to various tests conducted to detect the presence of disorders among animals. They are conducted by analyzing the samples of blood, feces and tissues of livestock, wild and pet animals. These tests are...
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...
2021 France Tumor Marker Testing Market--Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This unique report provides information and analysis not...
2021 France Diagnostics Market Shares, Segmentation Forecasts, Emerging Opportunities and Growth Strategies for Suppliers
This unique report provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific...
2021 France Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This comprehensive report is designed...
Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics.The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.